(Q39995812)

16 September 2017

title

Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro (English)

1 reference

16 September 2017

0 references

3

August Heidland

1 reference

16 September 2017

Ursula Schmid

1

1 reference

16 September 2017

Helga Stopper

series ordinal

2

1 reference

16 September 2017

Nicole Schupp

series ordinal

4

1 reference

16 September 2017

publication date

1 July 2008

1 reference

Diabetes - Metabolism: Research and Reviews

16 September 2017

published in

1 reference

16 September 2017

volume

24

1 reference

16 September 2017

issue

5

1 reference

16 September 2017

page(s)

371-377

1 reference

The in vitro micronucleus test: from past to future.

16 September 2017

cites work

1 reference

The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations

21 January 2018

1 reference

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

7 January 2021

Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats

1 reference

7 January 2021

Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

7 January 2021

Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes

1 reference

7 January 2021

Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats

1 reference

7 January 2021

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

1 reference

7 January 2021

4-Nitroquinoline 1-oxide forms 8-hydroxydeoxyguanosine in human fibroblasts through reactive oxygen species

1 reference

7 January 2021

Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells

1 reference

7 January 2021

Angiotensin-converting enzyme and lipoprotein(a) as risk factors for myocardial infarction

1 reference

7 January 2021

The comet assay for DNA damage and repair: principles, applications, and limitations

1 reference

7 January 2021

A simple technique for quantitation of low levels of DNA damage in individual cells

1 reference

7 January 2021

Genotoxicity of advanced glycation end products: involvement of oxidative stress and of angiotensin II type 1 receptors

1 reference

7 January 2021

Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration

1 reference

7 January 2021

Antioxidant activity of dietary polyphenols as determined by a modified ferric reducing/antioxidant power assay.

1 reference

7 January 2021

The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay

1 reference

7 January 2021

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

1 reference

7 January 2021

Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose

1 reference

7 January 2021

Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.

1 reference

7 January 2021

Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.860

1 reference

16 September 2017

1 reference